Entasis Therapeutics Holdings Inc.
(NASDAQ GM: ETTX)
Rigrodsky Law, P.A. is investigating Entasis Therapeutics Holdings Inc. (“Entasis”) regarding possible breaches of fiduciary duties and other violations of law related to Entasis’ agreement to be acquired by Innoviva Inc. Under the terms of the agreement, Entasis’ shareholders will receive $2.20 in cash for each share of Entasis common stock they own.